Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02561754 · ClinicalTrials.gov registry record · NA
Weight Management for Adolescents With IDD
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT02561754: Completed NA study, sponsored by University of Kansas Medical Center.
NCT02561754 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02561754, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
The goal of this study is to explore the impact of two different diets (conventional vs. enhanced stop light) and two different delivery systems (face-to-face vs. remote) on weight across 18 months in overweight and obese adolescents with intellectual and developmental disabilities.
Primary Outcome
Participants will be weighed in shorts and a t-shirt , on a calibrated scale to the nearest 0.1 kg.
Interventions
- DIETARY_SUPPLEMENT Enhanced Stop Light Diet (eSLD)
- DIETARY_SUPPLEMENT Conventional Diet (CD)
- BEHAVIORAL Face-to-face (FTF)
- BEHAVIORAL Technology (TECH)
- OTHER iPad with FaceTime
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2015-03 |
| Est. Completion | 2021-05-05 |
| Phase | NA |
What the finished NCT02561754 record still lists
NCT02561754 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 5 interventions - of which Enhanced Stop Light Diet (eSLD) is the first listed.
NCT02561754 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02561754 about?
NCT02561754 is a clinical study titled "Weight Management for Adolescents With IDD". The goal of this study is to explore the impact of two different diets (conventional vs. enhanced stop light) and two different delivery systems (face-to-face vs. remote) on weight across 18 months in overweight and obese adolescents with intellectual and developmental disabilities.
What is the current status of trial NCT02561754?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2015-03. Estimated completion is 2021-05-05.
What interventions are being tested in trial NCT02561754?
The interventions under investigation include: Enhanced Stop Light Diet (eSLD) (DIETARY_SUPPLEMENT), Conventional Diet (CD) (DIETARY_SUPPLEMENT), Face-to-face (FTF) (BEHAVIORAL), Technology (TECH) (BEHAVIORAL), iPad with FaceTime (OTHER).
Who is sponsoring clinical trial NCT02561754?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02561754's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia